Solid Biosciences
SLDB
SLDB
91 hedge funds and large institutions have $184M invested in Solid Biosciences in 2021 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 22 increasing their positions, 30 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
91
Holders Change
-1
Holders Change %
-1.09%
% of All Funds
1.6%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
22
Reduced
30
Closed
15
Calls
$567K
Puts
$527K
Net Calls
+$40K
Net Calls Change
-$316K
Top Buyers
| 1 |
AG
1
Artal Group
Luxembourg
|
$7.17M |
| 2 |
2
BlackRock
New York
|
$10.8M |
| 3 |
3
Alyeska Investment Group
Chicago,
Illinois
|
$2.11M |
| 4 |
4
Goldman Sachs
New York
|
$766K |
| 5 |
PAM
5
Panagora Asset Management
Boston,
Massachusetts
|
$286K |
Top Sellers
| 1 |
MWNA
1
Marshall Wace North America
New York
|
$626K |
| 2 |
2
Two Sigma Advisers
New York
|
$1.31M |
| 3 |
3
Two Sigma Investments
New York
|
$429K |
| 4 |
BC
4
Boxer Capital
San Diego,
California
|
$8.93M |
| 5 |
5
Marshall Wace
London,
United Kingdom
|
$401K |
